DMK PHARMACEUTICALS CORPORATION Embedded Derivative, Gain on Embedded Derivative
DMK PHARMACEUTICALS CORPORATION reported Embedded Derivative, Gain on Embedded Derivative of $2.60 million for the 6-month period ending 2013-09-30, per its 10-Q filed 2013-11-13.
Discontinued › Income Statement › Other Income
us-gaap:EmbeddedDerivativeGainOnEmbeddedDerivative · last filed 2013-11-13
- DMK PHARMACEUTICALS CORPORATION embedded derivative, gain on embedded derivative for the quarter ending 2013-09-30 was $2.54M, a 274.63% increase year-over-year.
- DMK PHARMACEUTICALS CORPORATION embedded derivative, gain on embedded derivative for the quarter ending 2013-06-30 was $61.64K.
- DMK PHARMACEUTICALS CORPORATION embedded derivative, gain on embedded derivative for the quarter ending 2013-03-31 was $30.73K.
- DMK PHARMACEUTICALS CORPORATION embedded derivative, gain on embedded derivative for the quarter ending 2012-12-31 was -$364.35K.
- DMK PHARMACEUTICALS CORPORATION embedded derivative, gain on embedded derivative for fiscal 2013 was -$1.39M.
| Period end | Embedded Derivative, Gain on Embedded Derivative 3 month | Embedded Derivative, Gain on Embedded Derivative 6 month | Embedded Derivative, Gain on Embedded Derivative 9 month | Embedded Derivative, Gain on Embedded Derivative 12 month |
|---|---|---|---|---|
| 2013-09-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-13 | $2.60M 10-Q · filed 2013-11-13 | $2.63M derived: sum of 3 quarters · filed 2013-11-13 | $2.27M derived: sum of 4 quarters · filed 2013-11-13 |
| 2013-06-30 | $61.64K 10-Q · filed 2013-08-19 | $92.36K derived: sum of 2 quarters · filed 2013-08-19 | -$271.98K derived: sum of 3 quarters · filed 2013-08-19 | $406.65K derived: sum of 4 quarters · filed 2013-11-13 |
| 2013-03-31 | $30.73K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-03 | -$333.62K derived: sum of 2 quarters · filed 2013-07-03 | $345.02K derived: sum of 3 quarters · filed 2013-11-13 | -$1.39M 10-K · filed 2013-07-03 |
| 2012-12-31 | -$364.35K 10-Q · filed 2013-02-19 | $314.29K derived: sum of 2 quarters · filed 2013-11-13 | -$1.42M 10-Q · filed 2013-02-19 | |
| 2012-09-30 | $678.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-13 | -$1.06M 10-Q · filed 2013-11-13 | ||
| 2012-06-30 | -$1.74M 10-Q · filed 2013-08-19 |